Tobacco smoking

Amwell Expands Presence in Australia with Amplar Health Partnership

Retrieved on: 
Wednesday, February 21, 2024
Medibank, Overweight, Patient satisfaction, Obesity, Partnership, Tobacco smoking, Conditional sentence, Risk, NHS, Death, Patient, Health literacy, Nursing

Amplar Health partnered with Amwell to support delivery of its prevention programs to reach more Australians at risk of chronic disease.

Key Points: 
  • Amplar Health partnered with Amwell to support delivery of its prevention programs to reach more Australians at risk of chronic disease.
  • Medibank customers will be the first to benefit from the Amplar Health and Amwell partnership, gaining access to a lifestyle management program that will launch soon.
  • Amplar Health will also be an Australian reseller of Amwell Automated Care and the SilverCloud® by Amwell® platforms and embed the technology in its prevention programs and services.
  • “Through our partnership with Amwell, we’re providing innovative resources and support that can help improve health literacy and facilitate better health outcomes for Australians.

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Retrieved on: 
Friday, February 16, 2024
FDA, Tobacco smoking, Food, Investigational New Drug, Safety, Quality control, Agency, Pharmaceutical industry

The pre-IND teleconference included representatives from various divisions of the FDA covering all regulatory aspects of the CannQuit-N development program.

Key Points: 
  • The pre-IND teleconference included representatives from various divisions of the FDA covering all regulatory aspects of the CannQuit-N development program.
  • The Agency had reviewed the CannQuit-N meeting package and provided recommendations on key design aspects of the proposed clinical trials, including the timing of efficacy endpoints and specific details on safety endpoints.
  • The FDA also confirmed proposed strategies for manufacturing and quality control are appropriate.
  • The productive discussion with the FDA is an important milestone for the development of CannQuit-N and will guide the continued development of the drug product.

QFG Slams WHO's Latest Report as 'Unscientific'

Retrieved on: 
Monday, January 15, 2024
Death, World Health Organization, Nicotine, Herbal cigarette, Tobacco smoking, Smoking, University, Cancer, Good, Risk, Public, Sale, WHO, Smoker, Tobacco, Diagnosis

"The best available clinical and population studies consistently show that vaping has led to adult smoking cessation.

Key Points: 
  • "The best available clinical and population studies consistently show that vaping has led to adult smoking cessation.
  • As a Filipino physician, Dr. Mata said the WHO's failure to differentiate between the risks of e-cigarettes and combustible tobacco is unscientific.
  • This new report perpetuates this tradition, calling for a ban on less risky alternatives while freely allowing the sale of tobacco.
  • However, for over a billion tobacco smokers worldwide, electronic nicotine delivery systems are part of the solution, not the problem," Prof. Britton said.

LUCY ANNOUNCES PUBLICATION OF PEER-REVIEWED BEHAVIORAL STUDY OF ITS NON-MEDICINAL NICOTINE GUM

Retrieved on: 
Wednesday, January 10, 2024
Death, Smoking, Female, Harm Reduction Journal, Nicotine, Tobacco smoking, Harm reduction, NRT, FDA, LUCY, Motivation, Smoke, Heated tobacco product, Prevalence, Tobacco

LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.

Key Points: 
  • LAS VEGAS, Jan. 10, 2024 /PRNewswire/ -- Lucy Goods (LUCY), an innovator of modern oral nicotine products, is proud to announce the publication of a behavioral study in Harm Reduction Journal.
  • Titled " Perceptions, intentions, and actual use of a consumer nicotine gum ," the study is the first to assess the potential of non-medicinal nicotine gum to switch adults who smoke to a potentially less harmful alternative.
  • Lucy's behavioral study in Harm Reduction Journal is first to assess nicotine gum as less harmful smoking alternative.
  • Quitting or cutting down consumption of cigarettes, vapes and other tobacco products were the most common motivation for trying LUCY Gum.

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

Retrieved on: 
Thursday, December 7, 2023
Urinary tract infection, JAMA, ASX, Risk, Woman, COPD, Prevalence, Disease, Lung cancer, SAN, RMD, Education, Gestational sac, Low, Air pollution, Emphysema, Chronic obstructive pulmonary disease, American Medical Association, JAMA Network Open, Tobacco smoking, World Health Organization, ResMed, Growth, Patient, Bronchitis, Journal, Female, Dust, Pharmaceutical industry

According to the World Health Organization , COPD is the third deadliest disease in the world.

Key Points: 
  • According to the World Health Organization , COPD is the third deadliest disease in the world.
  • Today, there are an estimated 480 million people who suffer from COPD.
  • This study in JAMA Network Open projects the increased regional and global burden of COPD by 2050 through an analysis of historical COPD prevalence and data on COPD risk factors such as tobacco smoking, outdoor air pollution, and household air pollution.
  • “The disproportionate growth of COPD among women is a critical finding as COPD has not always been as prevalent in women.

EGFR Tests Market Forecasts to 2033: Comprehensive Analysis of Size, Share, Regulatory Landscape and Global Trends - ResearchAndMarkets.com

Retrieved on: 
Friday, December 22, 2023
Medical Devices, Health, Naʽat, Metastasis, Point mutation, Woman, Afatinib, Country, Male, Smoking, EGFR, SWOT, Apoptosis, Lung cancer, Adenocarcinoma, Cancer, Region, Gefitinib, Market access, Deletion, Tobacco smoking, Patient, Internet, Female, Retail

The "EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
  • The model includes EGFR Immunohistochemistry Tests, EGFR Sanger Sequencing Tests, EGFR Nucleic Acid Amplification Tests (NAATs), and EGFR Other Tests (EGFR ISH and Mass Array tests).
  • Key Inclusions of the market model are:
    Currently marketed EGFR Tests and evolving competitive landscape:
    Insightful review of the key industry trends.
  • Global, Regional and Country level market specific insights:
    Qualitative market specific information is available with global trends further broken down into regional trends.

New Canadian Cancer Statistics report reveals lung cancer death rates are declining faster than any other cancer type in Canada

Retrieved on: 
Wednesday, November 8, 2023
Tobacco industry, Survival, Cervical cancer, Incidence, American Cancer Society, Government, Statistics Canada, Lung cancer, American Cancer Society Cancer Action Network, Mortality, Prevalence, CCS, Tobacco smoking, Legislation, Workplace, News, Air pollution, Probability, Statistics, Research, HIV disease progression rates, CAT, Smoking, Tobacco, Surveillance, Lung, Disease, Risk, Neoplasm, Immune system, Annual report, Medicine, Public Health Agency, Asbestos, Recurrence, Anne, Leukemia, Senior, Cancer, Investment, Public Health Agency of Canada, Patient, Pain, Empathy, Prognosis, Canadian Cancer Society, Acceleration, Dietary supplement, Pharmaceutical industry, Birth control, Uranium mining, Medical imaging

The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.

Key Points: 
  • The annual report – Canadian Cancer Statistics 2023 – was developed by the Canadian Cancer Statistics Advisory Committee in collaboration with CCS, Statistics Canada and the Public Health Agency of Canada.
  • While the age-standardized lung cancer death rates have decreased substantially, an estimated 20,600 people are expected to die from lung cancer (9,800 females and 10,800 males) in Canada in 2023.
  • The most significant reason that lung cancer death rates are improving is due to a reduction in commercial tobacco use, which is the leading risk factor for lung cancer.
  • "By investing more into lung cancer research, we gain critical insights about lung cancer and disease progression that will enable us to develop better treatments for lung cancer patients."

National Survey Shows Drop in E-Cigarette Use Among High School Students

Retrieved on: 
Thursday, November 2, 2023
FDA, Sale, Fruit, Physical examination, Food, Health, Korea Disease Control and Prevention Agency, Tobacco smoking, Regulation of tobacco by the U.S. Food and Drug Administration, Conflict, Center for Tobacco Products, Ice, CMP, CDC, Candy, Public, Heated tobacco product, Menthol, JUUL, Tobacco

SILVER SPRING, Md., Nov. 2, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), released data from the 2023 National Youth Tobacco Survey (NYTS) on tobacco product use among U.S. youth. The findings, which were collected between March and June 2023, show that 10% of U.S. middle and high school students (2.8 million youth) reported current use of any tobacco product.

Key Points: 
  • Among U.S. high school students, current overall tobacco product use declined during 2022-2023 (16.5% to 12.6%).
  • Among high school students, declines in current use were also observed during 2022-2023 for cigars and overall combustible tobacco smoking, representing all-time lows.
  • Although a decrease in e-cigarette use was observed among high school students, among middle school students there was an increase in current overall tobacco product use (4.5% to 6.6%) and multiple tobacco product use (1.5% to 2.5%).
  • E-cigarettes remained the most commonly used tobacco product among both high school and middle school students for the 10th year in a row.

Smoke Free Sweden: Health Experts Condemn ‘Backward’ Ban on Lifeline for Smokers

Retrieved on: 
Wednesday, September 13, 2023
Retail, Health, Other Consumer, Consumer, Other Retail, Tobacco, Other Health, Smoke, Smoker, Prevalence, Policy, Cancer, Movement, Government, Science, Death, United Kingdom, Smoking, Tobacco smoking, Birth control, Renewable energy, EU

Dr. Human continued, “Around the world, alternative nicotine products are helping to save millions of lives by giving smokers an escape from combustible cigarettes.

Key Points: 
  • Dr. Human continued, “Around the world, alternative nicotine products are helping to save millions of lives by giving smokers an escape from combustible cigarettes.
  • They are proven to be at least 95% less harmful than cigarettes and the most effective way for smokers to quit.
  • “Sweden is leading the way for other nations, such as the United Kingdom where the health service is giving free vape kits to smokers to help them quit.
  • Smoke Free Sweden is led by Health Diplomats, a global network of public health experts committed to developing and delivering solutions to global health-related problems.

What's in vapes? Toxins, heavy metals, maybe radioactive polonium

Retrieved on: 
Thursday, August 10, 2023
People, Carcinogen, Nicotine, Urinary tract infection, Aerosol, Atmosphere, Urine, Marketing, Organic compound, Propylene glycol, Cancer, Eating, Lead, Research, Plant, Soil, Chromium, Laboratory, Nickel, Polonium, Blood, Particulates, Arsenic, Acetaldehyde, Heat, Heated tobacco product, Smoking, News, Tobacco smoking, Saliva, Herbal cigarette, Tobacco, Environmental remediation, Natural gas, Dietary supplement, Maple syrup

If you asked me what’s in e-cigarettes, disposable vapes or e-liquids, my short answer would be “we don’t fully know”.

Key Points: 
  • If you asked me what’s in e-cigarettes, disposable vapes or e-liquids, my short answer would be “we don’t fully know”.
  • E-cigarettes’ risk to health varies depending on many factors including which device or flavours are used, and how people use them.
  • So vapers just don’t know what they’re inhaling and cannot be certain of the health impacts.

What do we know?

    • Ingredients include nicotine, flavouring chemicals, and the liquids that carry them – primarily propylene glycol and glycerine.
    • Concerningly, we also find volatile organic compounds, particulate matter and carcinogens (agents that can cause cancer), many of which we know are harmful.
    • Our previous research also found 2-chlorophenol in about half of e-liquids users buy to top-up re-fillable e-cigarettes.

How about polonium?

    • That’s because tobacco plants absorb it and other radioactive materials from the soil, air and high-phosphate fertiliser.
    • Although it is feasible if the glycerine in e-liquids comes from plants and similar fertilisers are used to grow them.

It’s not just the ingredients

    • Aside from their ingredients, the materials e-cigarette devices are made from can end up in our bodies.
    • Toxic metals and related substances such as arsenic, lead, chromium and nickel can be detected in both e-liquids and vapers’ urine, saliva and blood.

That’s not all


    The process of heating e-liquids to create an inhalable aerosol also changes their chemical make-up to produce degradation products. These include:
    • However due to different devices and how the samples are collected, the levels measured vary widely between studies.
    • Often, the levels are very low, leading to proponents of vaping arguing e-cigarettes are far safer than tobacco smoking.
    • People who buy tobacco cigarettes are also confronted with a plethora of warnings about the hazards of smoking, while vapers generally are not.

How about labelling?

    • Even if labels are present, they don’t always reflect what’s in the product.
    • Nicotine concentration of e-liquids is often quite different to what is on the label, and “nicotine-free” e-liquids often contain nicotine.
    • However mixing them into e-liquids, heating and inhaling them is a very different type of exposure, compared to eating them.
    • The list is so short because we don’t have enough information on the health effects if inhaled of other flavouring chemicals, and their interactions with other e-liquid ingredients.

Where to next?


    For us to better assess the health risks of vapes, we need to learn more about:
    Finally, we need to know more about how people use e-cigarettes so we can better understand and quantify the health risks in the real world.